157 Dems Urge Court To Lift FDA’s Mifepristone Prescribing Restrictions

By Beth Wang / February 17, 2021 at 2:24 PM
More than 150 Democratic members of Congress and 23 attorneys general are backing plaintiffs in an appeals case that seeks to prevent FDA from enforcing in-person prescribing restrictions for the abortion medication mifepristone. The lawmakers assert FDA’s prescribing and dispensing restrictions conflict with the Food, Drug and Cosmetic Act, and they, like the attorneys general, argue the restrictions exacerbate health disparities. Women’s health advocacy organizations have called for President Joe Biden to force FDA to loosen the restrictions, but the...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.